... Here, we reported a novel calmodulin-lysine N-methyltransferase (CAMKMT)–ALK fusion in a patient with PPMA... This first report of a CAMKMT-ALK fusion expands the spectrum of ALK fusion variants and supports comprehensive genomic profiling in PPMA to optimize therapeutic options. READ ARTICLE
Journal of Thoracic Oncology DOI:10.1016/j.jtho.2018.09.020
Authors: Xueting Hu, Qiang Cui, Minghui Wang